Global Neurointerventional Market Trends and Drivers, Restraints, and Opportunities 2017-2023
Global Neurointerventional Devices Market: Drivers, Opportunities, Trends, and Forecasts: 2017–2023
Overview: Neurointerventional is a complex medical specialty concerned with individuals suffering from neuro-related diseases and disorders. The nervous system is prone to several diseases that affect the brain, spine, peripheral nerves, and spinal cord. Symptoms, such as muscle weakness, seizures, perception, partial or complete analysis, cognition or emotional state, loss of bowel, and bladder control, are due to various neurological problems. Neurosurgery is the most advanced and modernized method for diagnosis and treatment, which includes computed tomography, magnetic resonance imaging (MRI), computer-assisted imaging, stereotactic radiosurgery, and magnetoencephalography. Some of the common neurosurgeries include craniotomy, microsurgery, oncological neurosurgery, neuroendoscopy (endoscopic endonasal surgery), and stereotactic neurosurgery. There is a wide availability of neurointerventional devices, such as flow diverters, embolic coils, aneurysm clips, neurovascular stents, aspiration devices, and support devices, that are used in performing neurosurgeries.
Cerebral disorders are among the most common neurological disorder and are prevalent in women. Changing lifestyles and stress have resulted in the development of a range of disorders like mood disorder and anxiety. Some of the most prevalent neurological disorders are stroke, multiple sclerosis, epilepsy, brain injuries, Alzheimer’s disease, and Parkinson disease, and neuro-infections. Neurological disorders cause more than 10% of the deaths worldwide. According to estimates by WHO, more than 350 million people are suffering from depression globally. According to the Brain Aneurysm Foundation, there are about 50 million brain aneurysm-related deaths every year, out of which half of the deaths occur in individuals who are aged below 50 years.
Factors, such as increased prevalence of neurological disorders, increasing awareness about new technologies, presence of large pool of patients in emerging markets, and advent of new innovative neurosurgical devices, such as flow diversion devices, neuroendovascular stents, liquid embolic, clot retrieval, and balloon catheters, are expected to drive the market growth during the forecast period. The market is expected to witness substantial growth due to the emergence of the neurointerventional technology that has eventually propelled innovation related to neurosurgical devices with the involvement of minimally invasive technique. The Neurointerventional Devices Market in India, Brazil, and China are expected to grow at a rapid pace during the forecast period mainly due to the presence of patients affected with various neurosurgical disorders.
Neurointerventional devices continue to demonstrate substantial improvements in patient outcomes by delivering high-quality and life-sustaining treatments. This factor provides huge potential for the market growth in both developed and developing countries with a wide range of opportunities. Vendors are investing hugely in R&D for the development of new products to gain the major market share globally.
Market Analysis: The Global Neurointerventional Devices Market is estimated to witness a CAGR of 12.3% during the forecast period 2017–2023. The Global Neurointerventional Devices Market is analyzed based on three segments, namely product type, end-users, and regions.
Product Analysis: The Global Neurointerventional Devices Market is segmented based on aneurysm devices, cerebral angiography and stenting devices, neurothrombectomy devices, and support devices. Aneurysm devices dominate the market and are the most innovative and fastest growing products in the Global Neurointerventional Devices Market. This segment is expected to grow at a CAGR 12.9% during the forecast period. The neuroendovascular treatment is widely accepted in most of the developed countries and have a strong hold of aneurysm devices like flow diverters, embolic coils, aneurysm clips, and platinum coils that are used in diverting and neuroendovascular coil treatment (aneurysm embolization/coiling). In 2015, about 44,500 neurovascular coiling procedures were performed in the US, 28,000 in Western Europe, and 5,500 in Germany. Therefore, the opportunities for growth in the emerging countries of LATAM and APAC remain vast. The increasing adoption of MI surgeries in treating neurological disorders, particularly in the elderly and the growing availability of devices contribute to the growth of the market.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific (APAC), and ROW. The Global Neurointerventional Devices Market is highly fragmented due to the presence of many vendors in the market. The innovations in the area of neurointervention have introduced products in the market from both leading and new entrants in the market. The vendors are focusing on the expansion of new applications to offer novel devices, which find use in increasing number of cerebral disorders. The key vendors focus on expanding their business by M&A, partnerships, and by attending conference and trade shows. North America is set to be the leading region for the growth of the neurointerventional devices market followed by Europe. There has been a significant increase in the number of individuals undergoing treatment for various neurosurgical procedures in the US. For instance, according to the American Academy of Neurology, neurological disorders accounted for 7% of all the global diseases in 2014.
Europe accounted for the second largest market with chronic pain being one of the major complications with the rising cerebral disorder cases. In 2015, the public spending on healthcare in Europe amounted to 18% of the overall government expenditure. The expenditure on chronic pain care with neurostimulation devices is directly reimbursed to hospitals within the NHS. Clinical evidence of neurosurgical devices when compared to other treatment, such as drug therapy, is expected to increase during the forecast period. Every year, approximately three million individuals sustain stenosis (25% of these require hospitalization), one million have stroke, and more than one million people are diagnosed with brain tumors in this region. In the Middle East and Sub-Saharan Africa, the mortality rate due to stroke is expected to triple in the next few years and is expected to lead to increased hospitalization and permanent disabilities.
The Neurosurgical Devices Market revenue in APAC is expected to reach $1,320 million by 2023, growing at a CAGR of 16.80% during the forecast period 2017–2023. Factors, such as high prevalence of neurological diseases, the presence of a large pool of patients, increase in disposable income, and rise in awareness about treatment for complex neurosurgeries, drive substantial market growth. The increase in government spending in healthcare, infrastructure, research centers, and the establishment of manufacturing facilities by major vendors are influencing the high growth of the market.
Key Players: DePuy Synthes, Inc., Medtronic PLC, Stryker Corp., Terumo Corp, and other predominate and niche players.
Competitive Analysis: Currently, the Global Neurointerventional Devices Market is dominated by aneurysm devices which have the maximum number of procedures and sales of flow diverters in the market. Vendors are focusing on investing a huge amount in R&D to develop new innovative products with newer applications to offer novel devices. Most of the vendors in the Global Neurointerventional Devices Market are focused on expanding their business through M&A, partnerships, and trade shows. Big players, such as DePuy Synthes, Inc., Terumo Corp, Medtronic PLC, and Stryker Corp., along with the collaboration with other universities and neurological research centers for clinical trials of neurology diseases are coming up with new neurosurgical devices in the market. Significant investments in R&D and the increasing awareness about complex neurosurgical procedures in the Global Neurointerventional Devices Market are expected to boost the market growth.
Benefits: The report provides complete details about the usage and adoption rate of neurosurgical devices for various neurological diseases and different regions. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the adoption of neurosurgical devices in the upcoming years along with the details of commercial neurosurgical devices available in the market. Moreover, the report provides details about the major challenges that impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture revenue in specific verticals and to analyze before investing or expanding the business in this market.
Key Stakeholders:
Overview: Neurointerventional is a complex medical specialty concerned with individuals suffering from neuro-related diseases and disorders. The nervous system is prone to several diseases that affect the brain, spine, peripheral nerves, and spinal cord. Symptoms, such as muscle weakness, seizures, perception, partial or complete analysis, cognition or emotional state, loss of bowel, and bladder control, are due to various neurological problems. Neurosurgery is the most advanced and modernized method for diagnosis and treatment, which includes computed tomography, magnetic resonance imaging (MRI), computer-assisted imaging, stereotactic radiosurgery, and magnetoencephalography. Some of the common neurosurgeries include craniotomy, microsurgery, oncological neurosurgery, neuroendoscopy (endoscopic endonasal surgery), and stereotactic neurosurgery. There is a wide availability of neurointerventional devices, such as flow diverters, embolic coils, aneurysm clips, neurovascular stents, aspiration devices, and support devices, that are used in performing neurosurgeries.
Cerebral disorders are among the most common neurological disorder and are prevalent in women. Changing lifestyles and stress have resulted in the development of a range of disorders like mood disorder and anxiety. Some of the most prevalent neurological disorders are stroke, multiple sclerosis, epilepsy, brain injuries, Alzheimer’s disease, and Parkinson disease, and neuro-infections. Neurological disorders cause more than 10% of the deaths worldwide. According to estimates by WHO, more than 350 million people are suffering from depression globally. According to the Brain Aneurysm Foundation, there are about 50 million brain aneurysm-related deaths every year, out of which half of the deaths occur in individuals who are aged below 50 years.
Factors, such as increased prevalence of neurological disorders, increasing awareness about new technologies, presence of large pool of patients in emerging markets, and advent of new innovative neurosurgical devices, such as flow diversion devices, neuroendovascular stents, liquid embolic, clot retrieval, and balloon catheters, are expected to drive the market growth during the forecast period. The market is expected to witness substantial growth due to the emergence of the neurointerventional technology that has eventually propelled innovation related to neurosurgical devices with the involvement of minimally invasive technique. The Neurointerventional Devices Market in India, Brazil, and China are expected to grow at a rapid pace during the forecast period mainly due to the presence of patients affected with various neurosurgical disorders.
Neurointerventional devices continue to demonstrate substantial improvements in patient outcomes by delivering high-quality and life-sustaining treatments. This factor provides huge potential for the market growth in both developed and developing countries with a wide range of opportunities. Vendors are investing hugely in R&D for the development of new products to gain the major market share globally.
Market Analysis: The Global Neurointerventional Devices Market is estimated to witness a CAGR of 12.3% during the forecast period 2017–2023. The Global Neurointerventional Devices Market is analyzed based on three segments, namely product type, end-users, and regions.
Product Analysis: The Global Neurointerventional Devices Market is segmented based on aneurysm devices, cerebral angiography and stenting devices, neurothrombectomy devices, and support devices. Aneurysm devices dominate the market and are the most innovative and fastest growing products in the Global Neurointerventional Devices Market. This segment is expected to grow at a CAGR 12.9% during the forecast period. The neuroendovascular treatment is widely accepted in most of the developed countries and have a strong hold of aneurysm devices like flow diverters, embolic coils, aneurysm clips, and platinum coils that are used in diverting and neuroendovascular coil treatment (aneurysm embolization/coiling). In 2015, about 44,500 neurovascular coiling procedures were performed in the US, 28,000 in Western Europe, and 5,500 in Germany. Therefore, the opportunities for growth in the emerging countries of LATAM and APAC remain vast. The increasing adoption of MI surgeries in treating neurological disorders, particularly in the elderly and the growing availability of devices contribute to the growth of the market.
Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific (APAC), and ROW. The Global Neurointerventional Devices Market is highly fragmented due to the presence of many vendors in the market. The innovations in the area of neurointervention have introduced products in the market from both leading and new entrants in the market. The vendors are focusing on the expansion of new applications to offer novel devices, which find use in increasing number of cerebral disorders. The key vendors focus on expanding their business by M&A, partnerships, and by attending conference and trade shows. North America is set to be the leading region for the growth of the neurointerventional devices market followed by Europe. There has been a significant increase in the number of individuals undergoing treatment for various neurosurgical procedures in the US. For instance, according to the American Academy of Neurology, neurological disorders accounted for 7% of all the global diseases in 2014.
Europe accounted for the second largest market with chronic pain being one of the major complications with the rising cerebral disorder cases. In 2015, the public spending on healthcare in Europe amounted to 18% of the overall government expenditure. The expenditure on chronic pain care with neurostimulation devices is directly reimbursed to hospitals within the NHS. Clinical evidence of neurosurgical devices when compared to other treatment, such as drug therapy, is expected to increase during the forecast period. Every year, approximately three million individuals sustain stenosis (25% of these require hospitalization), one million have stroke, and more than one million people are diagnosed with brain tumors in this region. In the Middle East and Sub-Saharan Africa, the mortality rate due to stroke is expected to triple in the next few years and is expected to lead to increased hospitalization and permanent disabilities.
The Neurosurgical Devices Market revenue in APAC is expected to reach $1,320 million by 2023, growing at a CAGR of 16.80% during the forecast period 2017–2023. Factors, such as high prevalence of neurological diseases, the presence of a large pool of patients, increase in disposable income, and rise in awareness about treatment for complex neurosurgeries, drive substantial market growth. The increase in government spending in healthcare, infrastructure, research centers, and the establishment of manufacturing facilities by major vendors are influencing the high growth of the market.
Key Players: DePuy Synthes, Inc., Medtronic PLC, Stryker Corp., Terumo Corp, and other predominate and niche players.
Competitive Analysis: Currently, the Global Neurointerventional Devices Market is dominated by aneurysm devices which have the maximum number of procedures and sales of flow diverters in the market. Vendors are focusing on investing a huge amount in R&D to develop new innovative products with newer applications to offer novel devices. Most of the vendors in the Global Neurointerventional Devices Market are focused on expanding their business through M&A, partnerships, and trade shows. Big players, such as DePuy Synthes, Inc., Terumo Corp, Medtronic PLC, and Stryker Corp., along with the collaboration with other universities and neurological research centers for clinical trials of neurology diseases are coming up with new neurosurgical devices in the market. Significant investments in R&D and the increasing awareness about complex neurosurgical procedures in the Global Neurointerventional Devices Market are expected to boost the market growth.
Benefits: The report provides complete details about the usage and adoption rate of neurosurgical devices for various neurological diseases and different regions. Thus, the key stakeholders can know about the major trends, drivers, investments, vertical player’s initiatives, and government initiatives toward the adoption of neurosurgical devices in the upcoming years along with the details of commercial neurosurgical devices available in the market. Moreover, the report provides details about the major challenges that impact the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture revenue in specific verticals and to analyze before investing or expanding the business in this market.
Key Stakeholders:
1 INDUSTRY OUTLOOK
1.1 Industry Overview
1.1.1 Neurostimulation Devices
1.1.2 Neurointerventional Devices
1.1.3 CSF Management Devices or Cerebrospinal Fluid Devices
1.1.4 Neurosurgical Navigation System
1.1.5 Other Neurosurgical Devices
1.2 Brain Aneurysm
1.3 Ruptured Aneurysm
1.4 Unruptured Aneurysm
1.5 Industry Trends
1.6 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
3.3.1 Neurosurgical Devices Market
3.3.2 Surgical Devices Market
3.3.3 Neurology Endoscopy Devices Market
3.3.4 Neurovascular Stent Retriever Market
3.3.5 Intracranial Pressure Monitor Market
4 MARKET OUTLOOK
4.1 Overview
4.2 Importance of Neurointerventional Devices
4.3 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 Global Neurointerventional Devices: Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in prevalence of neurological disorders
5.2.1.2 Growing popularity of MI neurosurgeries
5.2.1.3 Advent of new innovative neurointerventional devices
5.2.1.4 Increasing market awareness and campaigns
5.2.2 Opportunities
5.2.2.1 Technological advancements
5.2.2.2 Emergence of neuro-interventional technology
5.2.2.3 Increase in demand for cerebral stenting procedures
5.2.2.4 Product pipeline
5.2.3 Restraints
5.2.3.1 Complications and risk associated with neurovascular procedures
5.2.3.2 High cost of neurointerventional procedures
5.2.3.3 Stringent regulatory framework and labeling requirement
5.2.3.4 Paucity of skilled surgeons
5.2.4 DRO – Impact Analysis
5.2.5 Key Stakeholders
6 TYPES: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Aneurysm Devices
6.2.1 Overview
6.2.2 Types of Aneurysm Devices
6.2.2.1 Flow diverters
6.2.2.2 Aneurysm clips
6.2.2.3 Embolic coils
6.2.2.4 Platinum coils
6.3 Cerebral Angiography and Stenting Devices
6.3.1 Overview
6.3.2 Types of Cerebral Angiography and Stenting Devices
6.3.2.1 Neurovascular stents
6.3.2.2 Embolic protection
6.4 Neurothrombectomy Devices
6.4.1 Overview
6.4.2 Types of Neurothrombectomy Devices
6.4.2.1 Aspiration devices
6.4.2.2 Clot retriever
6.5 Support Devices
6.5.1 Overview
6.5.2 Types of Support Devices
6.5.2.1 Microcatheters
6.5.2.2 Micro guidewires
7 END USER: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Hospitals
7.3 Ambulatory Care
7.3.1 ASCs in the Americas
7.3.1.1 US
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 ASCs in the EMEA Region
7.3.2.1 France
7.3.2.2 UK
7.3.2.3 Israel
7.3.2.4 Africa
7.3.3 ASCs in the APAC Region
7.3.3.1 Australia
7.3.3.2 India
7.3.3.3 China
7.4 Trauma Centers
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 Market Overview
8.3 Europe
8.3.1 Market Overview
8.4 APAC
8.4.1 Market Overview
8.5 ROW
8.5.1 Market Overview
9 COMPETITIVE LANDSCAPE
9.1 Overview
10 VENDOR PROFILES
10.1 Medtronic PLC
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 Stryker Corp.
10.2.1 Overview
10.2.2 Business Units
10.2.3 Geographic Presence
10.2.4 Business Focus
10.2.5 SWOT Analysis
10.2.6 Business Strategies
10.3 DePuy Synthes, Inc.
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Terumo Corp
10.4.1 Overview
10.4.2 Business Units
10.4.3 Geographic Presence
10.4.4 Business Focus
10.4.5 SWOT Analysis
10.4.6 Business Strategies
10.5 Boston Scientific Corp.
10.5.1 Overview
10.5.2 Business Units
10.5.3 Geographic Presence
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
11 COMPANIES TO WATCH FOR
11.1 Terumo Corp.
11.2 St. Jude Medical Inc. (now Abbott)
11.2.1 Overview
11.2.2 Key Highlights
11.2.3 Business Strategies
11.3 ASAHI INTECC CO., LTD.
11.3.1 Overview
11.3.2 Key Highlights
11.3.3 Business Strategies
11.4 B. Braun Melsungen AG
11.4.1 Overview
11.4.2 Key Highlights
11.4.3 Business Strategies
11.5 Penumbra Inc.
11.5.1 Overview
11.5.2 Key Highlights
11.5.3 Business Strategies
11.6 BALT Extrusion S.A.
11.6.1 Overview
11.6.2 Key Highlights
11.6.3 Business Strategies
11.7 Cyberonics Inc. (LivaNova PLC)
11.7.1 Overview
11.7.2 Business Strategies
11.8 Cook Medical Inc.
11.8.1 Overview
11.8.2 Key Highlights
11.8.3 Business Strategies
Other prominent vendors
Annexure
Abbreviations
1.1 Industry Overview
1.1.1 Neurostimulation Devices
1.1.2 Neurointerventional Devices
1.1.3 CSF Management Devices or Cerebrospinal Fluid Devices
1.1.4 Neurosurgical Navigation System
1.1.5 Other Neurosurgical Devices
1.2 Brain Aneurysm
1.3 Ruptured Aneurysm
1.4 Unruptured Aneurysm
1.5 Industry Trends
1.6 PEST Analysis
2 REPORT OUTLINE
2.1 Report Scope
2.2 Report Summary
2.3 Research Methodology
2.4 Report Assumptions
3 MARKET SNAPSHOT
3.1 Total Addressable Market (TAM)
3.2 Segmented Addressable Market (SAM)
3.3 Related Markets
3.3.1 Neurosurgical Devices Market
3.3.2 Surgical Devices Market
3.3.3 Neurology Endoscopy Devices Market
3.3.4 Neurovascular Stent Retriever Market
3.3.5 Intracranial Pressure Monitor Market
4 MARKET OUTLOOK
4.1 Overview
4.2 Importance of Neurointerventional Devices
4.3 Porter 5(Five) Forces
5 MARKET CHARACTERISTICS
5.1 Evolution
5.2 Global Neurointerventional Devices: Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in prevalence of neurological disorders
5.2.1.2 Growing popularity of MI neurosurgeries
5.2.1.3 Advent of new innovative neurointerventional devices
5.2.1.4 Increasing market awareness and campaigns
5.2.2 Opportunities
5.2.2.1 Technological advancements
5.2.2.2 Emergence of neuro-interventional technology
5.2.2.3 Increase in demand for cerebral stenting procedures
5.2.2.4 Product pipeline
5.2.3 Restraints
5.2.3.1 Complications and risk associated with neurovascular procedures
5.2.3.2 High cost of neurointerventional procedures
5.2.3.3 Stringent regulatory framework and labeling requirement
5.2.3.4 Paucity of skilled surgeons
5.2.4 DRO – Impact Analysis
5.2.5 Key Stakeholders
6 TYPES: MARKET SIZE AND ANALYSIS
6.1 Overview
6.2 Aneurysm Devices
6.2.1 Overview
6.2.2 Types of Aneurysm Devices
6.2.2.1 Flow diverters
6.2.2.2 Aneurysm clips
6.2.2.3 Embolic coils
6.2.2.4 Platinum coils
6.3 Cerebral Angiography and Stenting Devices
6.3.1 Overview
6.3.2 Types of Cerebral Angiography and Stenting Devices
6.3.2.1 Neurovascular stents
6.3.2.2 Embolic protection
6.4 Neurothrombectomy Devices
6.4.1 Overview
6.4.2 Types of Neurothrombectomy Devices
6.4.2.1 Aspiration devices
6.4.2.2 Clot retriever
6.5 Support Devices
6.5.1 Overview
6.5.2 Types of Support Devices
6.5.2.1 Microcatheters
6.5.2.2 Micro guidewires
7 END USER: MARKET SIZE AND ANALYSIS
7.1 Overview
7.2 Hospitals
7.3 Ambulatory Care
7.3.1 ASCs in the Americas
7.3.1.1 US
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 ASCs in the EMEA Region
7.3.2.1 France
7.3.2.2 UK
7.3.2.3 Israel
7.3.2.4 Africa
7.3.3 ASCs in the APAC Region
7.3.3.1 Australia
7.3.3.2 India
7.3.3.3 China
7.4 Trauma Centers
8 REGIONS: MARKET SIZE AND ANALYSIS
8.1 Overview
8.2 North America
8.2.1 Market Overview
8.3 Europe
8.3.1 Market Overview
8.4 APAC
8.4.1 Market Overview
8.5 ROW
8.5.1 Market Overview
9 COMPETITIVE LANDSCAPE
9.1 Overview
10 VENDOR PROFILES
10.1 Medtronic PLC
10.1.1 Overview
10.1.2 Business Units
10.1.3 Geographic Presence
10.1.4 Business Focus
10.1.5 SWOT Analysis
10.1.6 Business Strategies
10.2 Stryker Corp.
10.2.1 Overview
10.2.2 Business Units
10.2.3 Geographic Presence
10.2.4 Business Focus
10.2.5 SWOT Analysis
10.2.6 Business Strategies
10.3 DePuy Synthes, Inc.
10.3.1 Overview
10.3.2 Business Units
10.3.3 Geographic Presence
10.3.4 Business Focus
10.3.5 SWOT Analysis
10.3.6 Business Strategies
10.4 Terumo Corp
10.4.1 Overview
10.4.2 Business Units
10.4.3 Geographic Presence
10.4.4 Business Focus
10.4.5 SWOT Analysis
10.4.6 Business Strategies
10.5 Boston Scientific Corp.
10.5.1 Overview
10.5.2 Business Units
10.5.3 Geographic Presence
10.5.4 Business Focus
10.5.5 SWOT Analysis
10.5.6 Business Strategies
11 COMPANIES TO WATCH FOR
11.1 Terumo Corp.
11.2 St. Jude Medical Inc. (now Abbott)
11.2.1 Overview
11.2.2 Key Highlights
11.2.3 Business Strategies
11.3 ASAHI INTECC CO., LTD.
11.3.1 Overview
11.3.2 Key Highlights
11.3.3 Business Strategies
11.4 B. Braun Melsungen AG
11.4.1 Overview
11.4.2 Key Highlights
11.4.3 Business Strategies
11.5 Penumbra Inc.
11.5.1 Overview
11.5.2 Key Highlights
11.5.3 Business Strategies
11.6 BALT Extrusion S.A.
11.6.1 Overview
11.6.2 Key Highlights
11.6.3 Business Strategies
11.7 Cyberonics Inc. (LivaNova PLC)
11.7.1 Overview
11.7.2 Business Strategies
11.8 Cook Medical Inc.
11.8.1 Overview
11.8.2 Key Highlights
11.8.3 Business Strategies
Other prominent vendors
Annexure
Abbreviations
LIST OF TABLES
Table 1 CLINICAL TRIALS OF NEUROINTERVENTIONAL DEVICES
Table 2 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY TYPES, 2016–2023 ($MILLION)
Table 3 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET ATTRACTIVENESS BY PRODUCT TYPES, 2016
Table 4 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY END-USERS
Table 5 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET REVENUE BY REGIONS FORECAST, 2016–2023 ($MILLION)
Table 6 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET ATTRACTIVENESS BY REGION, 2016
Table 7 DRO (AMERICAS)
Table 8 DRO (EUROPE)
Table 9 DRO (APAC)
Table 10 DRO (ROW)
Table 11 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY VENDOR RANKING, 2016
Table 12 MEDTRONIC PLC: PRODUCT OFFERINGS
Table 13 MEDTRONIC PLC: RECENT DEVELOPMENTS
Table 14 STRYKER CORP.: PRODUCT OFFERINGS
Table 15 STRYKER CORP.: RECENT DEVELOPMENTS
Table 16 DEPUY SYNTHES, INC.: PRODUCT OFFERINGS
Table 17 DEPUY SYNTHES, INC.: RECENT DEVELOPMENTS
Table 18 TERUMO CORP.: PRODUCT OFFERINGS
Table 19 TERUMO CORP.: RECENT DEVELOPMENTS
Table 20 BOSTON SCIENTIFIC CORP.: PRODUCT OFFERINGS
Table 21 BOSTON SCIENTIFIC CORP.: RECENT DEVELOPMENTS
Table 22 ST. JUDE MEDICAL INC.: SNAPSHOT
Table 23 ST. JUDE MEDICAL INC.: RECENT DEVELOPMENTS
Table 24 ASAHI INTECC CO., LTD.: SNAPSHOT
Table 25 B. BRAUN MELSUNGEN AG: SNAPSHOT
Table 26 B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
Table 27 PENUMBRA INC.: SNAPSHOT
Table 28 BALT EXTRUSION S.A.: SNAPSHOT
Table 29 CYBERONICS INC.: SNAPSHOT
Table 30 CYBERONICS INC.: RECENT DEVELOPMENTS
Table 31 COOK MEDICAL INC.: SNAPSHOT
Table 1 CLINICAL TRIALS OF NEUROINTERVENTIONAL DEVICES
Table 2 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY TYPES, 2016–2023 ($MILLION)
Table 3 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET ATTRACTIVENESS BY PRODUCT TYPES, 2016
Table 4 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY END-USERS
Table 5 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET REVENUE BY REGIONS FORECAST, 2016–2023 ($MILLION)
Table 6 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET ATTRACTIVENESS BY REGION, 2016
Table 7 DRO (AMERICAS)
Table 8 DRO (EUROPE)
Table 9 DRO (APAC)
Table 10 DRO (ROW)
Table 11 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY VENDOR RANKING, 2016
Table 12 MEDTRONIC PLC: PRODUCT OFFERINGS
Table 13 MEDTRONIC PLC: RECENT DEVELOPMENTS
Table 14 STRYKER CORP.: PRODUCT OFFERINGS
Table 15 STRYKER CORP.: RECENT DEVELOPMENTS
Table 16 DEPUY SYNTHES, INC.: PRODUCT OFFERINGS
Table 17 DEPUY SYNTHES, INC.: RECENT DEVELOPMENTS
Table 18 TERUMO CORP.: PRODUCT OFFERINGS
Table 19 TERUMO CORP.: RECENT DEVELOPMENTS
Table 20 BOSTON SCIENTIFIC CORP.: PRODUCT OFFERINGS
Table 21 BOSTON SCIENTIFIC CORP.: RECENT DEVELOPMENTS
Table 22 ST. JUDE MEDICAL INC.: SNAPSHOT
Table 23 ST. JUDE MEDICAL INC.: RECENT DEVELOPMENTS
Table 24 ASAHI INTECC CO., LTD.: SNAPSHOT
Table 25 B. BRAUN MELSUNGEN AG: SNAPSHOT
Table 26 B. BRAUN MELSUNGEN AG: RECENT DEVELOPMENTS
Table 27 PENUMBRA INC.: SNAPSHOT
Table 28 BALT EXTRUSION S.A.: SNAPSHOT
Table 29 CYBERONICS INC.: SNAPSHOT
Table 30 CYBERONICS INC.: RECENT DEVELOPMENTS
Table 31 COOK MEDICAL INC.: SNAPSHOT
LIST OF CHARTS
Chart 1 NEUROSURGICAL DEVICES MARKET SEGMENTATION
Chart 2 NEUROLOGICAL SYMPTOMS FOR UNRUPTURED ANEURYSM
Chart 3 PEST ANALYSIS OF GLOBAL NEUROSURGICAL DEVICES MARKET
Chart 4 RESEARCH METHODOLOGY OF GLOBAL NEUROINTERVENTIONAL DEVICES MARKET
Chart 5 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION
Chart 6 WORLDWIDE NEUROINTERVENTIONAL DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 7 PORTER 5 FORCES ON GLOBAL NEUROINTERVENTIONAL DEVICES MARKET
Chart 8 KEY DEVELOPMENTS AND INVENTIONS IN NEUROSURGICAL PROCEDURES
Chart 9 DRO – IMPACT ANALYSIS OF GLOBAL NEUROINTERVENTIONAL DEVICES MARKET
Chart 10 KEY STAKEHOLDERS
Chart 11 GLOBAL NEUROSURGICAL DEVICES MARKET BY TYPE SEGMENTATION, 2016 (%)
Chart 12 GLOBAL NEUROSURGICAL DEVICES MARKET BY TYPE SEGMENTATION, 2023 (%)
Chart 13 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENTATION
Chart 14 WORLDWIDE ANEURYSM DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 15 WORLDWIDE CEREBRAL ANGIOGRAPHY AND STENTING DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 16 WORLDWIDE NEUROTHROMBECTOMY DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 17 WORLDWIDE SUPPORT DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 18 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY END-USER SEGMENTATION, 2016 (%)
Chart 19 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 20 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (%)
Chart 21 NEUROINTERVENTIONAL DEVICES MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 22 NEUROINTERVENTIONAL DEVICES MARKET REVENUE IN THE EUROPE REGION, 2016–2023 ($MILLION)
Chart 23 NEUROINTERVENTIONAL DEVICES MARKET REVENUE IN THE APAC REGION, 2016–2023 ($MILLION)
Chart 24 NEUROINTERVENTIONAL DEVICES MARKET REVENUE IN THE ROW, 2016–2023 ($MILLION)
Chart 25 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 26 MEDTRONIC PLC: BUSINESS UNITS
Chart 27 MEDTRONIC PLC: GEOGRAPHICAL PRESENCE
Chart 28 MEDTRONIC PLC: SWOT ANALYSIS
Chart 29 STRYKER CORP.: OVERVIEW SNAPSHOT
Chart 30 STRYKER CORP.: BUSINESS UNITS
Chart 31 STRYKER CORP.: GEOGRAPHIC PRESENCE
Chart 32 STRYKER CORP.: SWOT ANALYSIS
Chart 33 DEPUY SYNTHES, INC.: OVERVIEW SNAPSHOT
Chart 34 DEPUY SYNTHES, INC.: BUSINESS UNITS
Chart 35 DEPUY SYNTHES, INC.: GEOGRAPHIC PRESENCE
Chart 36 DEPUY SYNTHES, INC.: SWOT ANALYSIS
Chart 37 TERUMO CORP.: OVERVIEW SNAPSHOT
Chart 38 TERUMO CORP.: BUSINESS UNITS
Chart 39 TERUMO CORP.: GEOGRAPHIC PRESENCE
Chart 40 TERUMO CORP.: SWOT ANALYSIS
Chart 41 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT
Chart 42 BOSTON SCIENTIFIC CORP.: BUSINESS UNIT
Chart 43 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE
Chart 44 BOSTON SCIENTIFIC CORP.: SWOT ANALYSIS
Chart 1 NEUROSURGICAL DEVICES MARKET SEGMENTATION
Chart 2 NEUROLOGICAL SYMPTOMS FOR UNRUPTURED ANEURYSM
Chart 3 PEST ANALYSIS OF GLOBAL NEUROSURGICAL DEVICES MARKET
Chart 4 RESEARCH METHODOLOGY OF GLOBAL NEUROINTERVENTIONAL DEVICES MARKET
Chart 5 GLOBAL MEDICAL DEVICES MARKET SEGMENTATION
Chart 6 WORLDWIDE NEUROINTERVENTIONAL DEVICES MARKET REVENUE, 2016–2023 ($MILLION)
Chart 7 PORTER 5 FORCES ON GLOBAL NEUROINTERVENTIONAL DEVICES MARKET
Chart 8 KEY DEVELOPMENTS AND INVENTIONS IN NEUROSURGICAL PROCEDURES
Chart 9 DRO – IMPACT ANALYSIS OF GLOBAL NEUROINTERVENTIONAL DEVICES MARKET
Chart 10 KEY STAKEHOLDERS
Chart 11 GLOBAL NEUROSURGICAL DEVICES MARKET BY TYPE SEGMENTATION, 2016 (%)
Chart 12 GLOBAL NEUROSURGICAL DEVICES MARKET BY TYPE SEGMENTATION, 2023 (%)
Chart 13 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY SEGMENTATION
Chart 14 WORLDWIDE ANEURYSM DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 15 WORLDWIDE CEREBRAL ANGIOGRAPHY AND STENTING DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 16 WORLDWIDE NEUROTHROMBECTOMY DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 17 WORLDWIDE SUPPORT DEVICES MARKET BY REVENUE, 2017–2023 ($MILLION)
Chart 18 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY END-USER SEGMENTATION, 2016 (%)
Chart 19 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2016 (%)
Chart 20 GLOBAL NEUROINTERVENTIONAL DEVICES MARKET BY GEOGRAPHICAL SEGMENTATION, 2023 (%)
Chart 21 NEUROINTERVENTIONAL DEVICES MARKET REVENUE IN NORTH AMERICA, 2016–2023 ($MILLION)
Chart 22 NEUROINTERVENTIONAL DEVICES MARKET REVENUE IN THE EUROPE REGION, 2016–2023 ($MILLION)
Chart 23 NEUROINTERVENTIONAL DEVICES MARKET REVENUE IN THE APAC REGION, 2016–2023 ($MILLION)
Chart 24 NEUROINTERVENTIONAL DEVICES MARKET REVENUE IN THE ROW, 2016–2023 ($MILLION)
Chart 25 MEDTRONIC PLC: OVERVIEW SNAPSHOT
Chart 26 MEDTRONIC PLC: BUSINESS UNITS
Chart 27 MEDTRONIC PLC: GEOGRAPHICAL PRESENCE
Chart 28 MEDTRONIC PLC: SWOT ANALYSIS
Chart 29 STRYKER CORP.: OVERVIEW SNAPSHOT
Chart 30 STRYKER CORP.: BUSINESS UNITS
Chart 31 STRYKER CORP.: GEOGRAPHIC PRESENCE
Chart 32 STRYKER CORP.: SWOT ANALYSIS
Chart 33 DEPUY SYNTHES, INC.: OVERVIEW SNAPSHOT
Chart 34 DEPUY SYNTHES, INC.: BUSINESS UNITS
Chart 35 DEPUY SYNTHES, INC.: GEOGRAPHIC PRESENCE
Chart 36 DEPUY SYNTHES, INC.: SWOT ANALYSIS
Chart 37 TERUMO CORP.: OVERVIEW SNAPSHOT
Chart 38 TERUMO CORP.: BUSINESS UNITS
Chart 39 TERUMO CORP.: GEOGRAPHIC PRESENCE
Chart 40 TERUMO CORP.: SWOT ANALYSIS
Chart 41 BOSTON SCIENTIFIC CORP.: OVERVIEW SNAPSHOT
Chart 42 BOSTON SCIENTIFIC CORP.: BUSINESS UNIT
Chart 43 BOSTON SCIENTIFIC CORP.: GEOGRAPHIC PRESENCE
Chart 44 BOSTON SCIENTIFIC CORP.: SWOT ANALYSIS
